On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services Network to deploy COVID-19 testing programs throughout the U.S. Todos will work closely with Meridian to help supplement COVID-19 testing products and services for its network of brick & mortar and mobile laboratories nationwide. Meridian successfully completed CLIA validation testing for Todos’ antibody test.

“As we continue to design and implement COVID-19 testing programs, it has become clear that the quality and strategies behind testing are critical to achieve measurable outcomes for our members,” said David Bloom, President of Meridian Health Services Network. “This partnership is an important step as we engage with state and local governments, as well as our existing self-insured employer groups and health services networks seeking solutions for the deployment of COVID-19 testing. Nationwide, testing is moving out of the realm of being solely focused on symptomatic patients, and as a result we have developed innovative, compliant solutions to make testing easy, accessible and well-coordinated for our members. We are especially excited about the potential for Todos’ 3C Protease At-Home Saliva test that it is developing in Israel with NLC Pharma in the coming months.”

Since 2000 Meridian HSN has been assisting Fortune 1000 businesses, cities, schools and hospitals in managing and lowering health, benefits and risk management costs through our network of services. Meridian serves thousands of patients daily through our Accountable Care Organization approach of assembling the nation’s leading providers into one resource led by our healthcare funding analysis. Our nationally recognized network is made up of health care providers, PBM management, PCP partners, telemedicine, as well as health and MSK assessment teams. Meridian clients average 10-20% savings on health and risk management costs compared to average industry costs. Meridian benefits average a 98% employee approval rating